KYU HYUN JUNG: Open Payments
NPI 1730630971 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 19 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $208 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $509 |
| Amgen Inc. | 1 | $123 |
| Novartis Pharmaceuticals Corporation | 1 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $62 |
| Philips North America LLC | 1 | $34 |
| Esperion Therapeutics, Inc. | 1 | $29 |
| Kestra Medical Technology Services, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: Wegovy, Ozempic, REPATHA, LEQVIO, JARDIANCE, MCOT, NEXLETOL, Assure WCD.
Industry payments across NY — which companies pay providers there.
